Épisodes

  • Impacting Lives of People with Diabetes in Resource Constrained Settings

    Impacting Lives of People with Diabetes in Resource Constrained Settings
    Oct 24 2025
    In this episode, Dr. Viswanathan Mohan, recipient of the inaugural EASD Global Impact Prize, reflects on his remarkable 50-year career transforming diabetes care in India and worldwide. From pioneering diabetes as a medical speciality and training over 29,000 educators, to leading translational research and nationwide screening initiatives, Dr. Mohan’s work has set new benchmarks in global health impact. He discusses the evolving causes of India’s diabetes epidemic, from genetics and high-carbohydrate diets to pollution and urbanisation, and the policies needed to address them. Dr. Mohan also explores how innovation, affordability, and access to technologies like continuous glucose monitoring (CGM) can bridge the care gap for millions, and shares his enduring hope for a future cure for type 1 diabetes. Join us to learn how one physician’s lifelong mission continues to inspire global change in diabetes prevention and treatment.
    Voir plus Voir moins
    15 min
  • Everything you want to know about Adipose Tissue: From Cellular Mechanisms to Clinical Complications

    Everything you want to know about Adipose Tissue: From Cellular Mechanisms to Clinical Complications
    Oct 17 2025
    In this episode, EASD TV host Vivienne Parry sits with Prof. Mikael Rydén (Karolinska Institute), recipient of the 40th Camillo Golgi Prize, about his groundbreaking research on adipose tissue. Prof. Rydén shares insights into how different fat cell subtypes influence disease progression, particularly in diabetes and obesity. His work highlights the potential of precision medicine in tailoring treatments based on the composition of adipose tissue, shifting the focus from generalised treatments to more personalised approaches. Join us for a deep dive into how Prof. Rydén’s research is revolutionising diabetes care and what it means for the future of metabolic health.
    Voir plus Voir moins
    12 min
  • Back to the future: Re-centring the Role of the Pancreas in Type 2 Diabetes

    Back to the future: Re-centring the Role of the Pancreas in Type 2 Diabetes
    Oct 10 2025
    In this episode, Dr Teresa Mezza, recipient of the 2025 EASD Minkowski Prize, takes listeners inside her pioneering research on the early mechanisms of type 2 diabetes. As both a clinician and researcher at the Fondazione Policlinico Universitario A. Gemelli in Rome, Dr Mezza studies patients before and after partial pancreatectomy, offering a unique perspective on beta cell adaptation, function, and decline. Her work is revealing early biomarkers that could identify individuals at risk of diabetes - even before hyperglycaemia develops - paving the way for earlier intervention and prevention. Dr Mezza also discusses the importance of translational research, the challenges facing young scientists, and her belief that perseverance and curiosity are the driving forces of meaningful discovery. Join us for this inspiring conversation about science, mentorship, and the future of diabetes research.
    Voir plus Voir moins
    8 min
  • Precision Diabetes: Learning From the Rare and Applying to the Common

    Precision Diabetes: Learning From the Rare and Applying to the Common
    Oct 2 2025
    In this episode, EASD host, Vivienne Parry sits down with 2025 EASD Claude Bernard Prize recipient, Prof. Andrew Hattersley, to reflect on his career which has transformed diabetes research and care worldwide. From the discovery of key genetic mutations in maturity onset diabetes of the young (MODY) and neonatal diabetes to establishing a global genetic testing programme that has helped patients in more than 100 countries, Prof. Hattersley has shaped our understanding of diabetes. Tune in to hear reflections on his early breakthroughs, the team collaborations that made them possible, and the far-reaching clinical impact of precision medicine for children and families worldwide. Looking to the future, he explores the next frontier: bringing personalised approached into type 2 diabetes care.
    Voir plus Voir moins
    10 min
  • Mitochondria, Insulin Resistance, and the Future of Diabetes Treatment

    Mitochondria, Insulin Resistance, and the Future of Diabetes Treatment
    Sep 25 2025
    In this episode, we meet Prof Gerald Shulman, recipient of this year’s EASD-Novo Nordisk Foundation Diabetes Prize for Excellence, whose pioneering research has reshaped our understanding of insulin resistance and its role in type 2 diabetes and beyond. Prof. Shulman shares insights from over four decades of research into how ectopic lipid accumulation disrupts insulin signalling, leading to diabetes, fatty liver disease, cardiovascular complications, cancers, and Alzheimer’s disease. He explains how his discoveries - from the role of diacylglycerols to innovative mitochondrial-targeted therapies now in clinical trials - could mark a paradigm shift in the treatment of insulin resistance. Join us for this inspiring conversation on the future of metabolic medicine and the exciting prospect of treating insulin resistance as a central target for preventing chronic disease.
    Voir plus Voir moins
    8 min
  • The Future of Diabetes Technology: Beyond Devices to Equity and Personalisation

    The Future of Diabetes Technology: Beyond Devices to Equity and Personalisation
    Jul 4 2025
    In this special episode, host Vivienne Parry is joined by experts Anna Krook (Karolinska Institute), Klemen Dovč (Ljubljana University Medical Centre), Peter Gillard (University Hospital Leuven), and Julia Mader (University of Graz) to explore the rapid evolution of diabetes technology. From continuous glucose monitors (CGMs) and automated insulin delivery (AID) systems to AI-powered apps and integrated health records, the panel discusses how these innovations are transforming care and what barriers remain. They unpack emerging trends in personalisation, device standardisation, and the urgent need for equitable access to ensure no one is left behind. The conversation draws on insights from Diabetologia’s 60th Anniversary Technology Supplement and Symposium (the official journal of the EASD), along with reflections from people living with diabetes themselves. The panel also explores a central question: how do we ensure everyone, from preschoolers to older adults, in both urban and rural settings, can benefit from these technologies? Tune in to hear what’s next for diabetes tech, and why centring people with diabetes in innovation is critical.
    Voir plus Voir moins
    12 min
  • Can Pre-Diabetes Remission Reduce Global Diabetes Incidences?

    Can Pre-Diabetes Remission Reduce Global Diabetes Incidences?
    Jun 27 2025
    In this episode, Dr Andreas Birkenfeld (Germany) and Dr Viswanathan Mohan, 1st EASD Diabetes Global Impact Prize winner (India), join host Vivienne Parry to explore the growing importance of recognising, screening and managing pre-diabetes on a global scale. They discuss how moving beyond diabetes remission to pre-diabetes remission could prevent long-term complications, and why strategic, risk-based screening could ease the economic burden on health systems. From policy change and health economics to public awareness and culturally tailored approaches, this episode highlights why proactive intervention in pre-diabetes is critical and what it will take to make it happen worldwide.
    Voir plus Voir moins
    11 min
  • What Will the Future Bring for People Living with Diabetes?

    What Will the Future Bring for People Living with Diabetes?
    Jun 20 2025
    What does the future hold for people living with diabetes? In this episode, our host Vivienne Parry together with diabetes advocates Bastian Hauck, Renza Scibilia and Christian Collin dives into recent advances in diabetes prevention, screening, and therapeutics - from GLP-1 drugs to innovative community-driven screening strategies. But as science accelerates, can our health systems and societies keep up? Join us for an eye-opening conversation on equity, access, and the power of community in reshaping diabetes care.
    Voir plus Voir moins
    20 min